Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Update

Posted by Sarita Garza on Jan 17th, 2026

Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) saw a significant drop in short interest in the month of December. As of December 31st, there was short interest totaling 7,741 shares, a drop of 57.7% from the December 15th total of 18,284 shares. Approximately 0.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 23,041 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 23,041 shares, the short-interest ratio is currently 0.3 days. Approximately 0.6% of the shares of the stock are short sold.

Global X HealthTech ETF Stock Performance

HEAL traded down $0.39 during midday trading on Friday, hitting $30.58. The stock had a trading volume of 6,256 shares, compared to its average volume of 13,451. Global X HealthTech ETF has a 1 year low of $24.48 and a 1 year high of $35.73. The business has a fifty day moving average of $30.44 and a 200 day moving average of $31.33. The company has a market cap of $42.20 million, a P/E ratio of 42.80 and a beta of 1.13.

Global X HealthTech ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Wednesday, January 7th. Shareholders of record on Tuesday, December 30th were issued a dividend of $0.0718 per share. The ex-dividend date was Tuesday, December 30th.

Institutional Trading of Global X HealthTech ETF

Hedge funds have recently made changes to their positions in the stock. Flow Traders U.S. LLC bought a new position in Global X HealthTech ETF in the 3rd quarter valued at approximately $368,000. Citadel Advisors LLC bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter worth $216,000. Raymond James Financial Inc. purchased a new position in shares of Global X HealthTech ETF in the third quarter worth $274,000. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF during the third quarter valued at $11,239,000. Finally, Glenmede Investment Management LP bought a new position in shares of Global X HealthTech ETF during the third quarter valued at $31,000.

Global X HealthTech ETF Company Profile

(Get Free Report)

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.